Shaanxi Giant Biotechnology Co., Ltd – Trademark Portfolio

Entity Type: 03

Shaanxi Giant Biotechnology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered.

No. 20, Zone C, Venture R&D Park,

No. 69, Jinye Road, High-tech Zone, Xi’an City 710000 Shaanxi

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #79383490
Registered 2023

Trademark Classifications

Shaanxi Giant Biotechnology Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shaanxi Giant Biotechnology Co., Ltd have?

Shaanxi Giant Biotechnology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shaanxi Giant Biotechnology Co., Ltd file in?

Shaanxi Giant Biotechnology Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What is Shaanxi Giant Biotechnology Co., Ltd's trademark registration success rate?

Shaanxi Giant Biotechnology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.